Organization (Academic)
University of Fribourg
ClinicalTrials.gov lists University of Fribourg as lead sponsor of 16 trials. It has 1 approved asset.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 3 registered with a 2026 start date. The dashed outline is the pace from the 3 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Unknown author Unknown author, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers University of Fribourg: 16 lead-sponsored trials and 1 legal-entity registration.
Disease areas (14)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Conversion Disorder | 3 |
| Somatoform Disorders | 3 |
| Anxiety Disorders | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Breast Neoplasms | 1 |
Showing 5 of 14 disease areas.
Trials by start year as sponsor or collaborator (11)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 4 |
| 2024 | 2 |
| 2023 | 2 |
| 2022 | 1 |
| 2021 | 2 |
| 2020 | 1 |
| 2019 | 1 |
| 2018 | 1 |
| 2015 | 2 |
Showing 10 of 11 years.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (1)
| Drug | Trials |
|---|---|
| Ecallantide | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 2 of 4 hit target (n=4) | 1 of 4 on time (n=4) |
Journals published in (47)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| BMJ open | 2 |
| Clinical cancer research : an official journal of the American Association for Cancer Research | 2 |
| Cognitive behaviour therapy | 2 |
| PloS one | 2 |
| Trials | 2 |
Showing 5 of 47 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 7 | 3 | 2024-08-06 |
Organization relationships (5)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| University of Zurich | Co sponsors trial with | 1 |
| Utah System of Higher Education | Co sponsors trial with | 1 |
| Centre Hospitalier Universitaire Vaudois | Co sponsors trial with | 1 |
| Insel Gruppe AG, University Hospital Bern | Co sponsors trial with | 1 |
| Hôpital Fribourgeois | Co sponsors trial with | 1 |
Latest dated events (28)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-09-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-07-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-05-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-12-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-08-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 28 events.
Biomarkers this organization publishes on (65)
Shown in this order: most publications first.
Showing 5 of 65 biomarkers.
On Scientist.com
University of Fribourg is listed as a research supplier in the Scientist.com network.
Our group is dedicated to provide bioinformatics support to life-science researchers of the University of Fribourg.
This includes the following activities:
- Project planing and grant writing
- Software testing and development
- Data management and analysis
- Training and Teaching
- Website
- www.unifr.ch/bugfri
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarker capability evidence.
Work with University of Fribourg - Bioinformatics Core on Scientist.com
For prices, more details, or to contact University of Fribourg - Bioinformatics Core, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.